## ACTIVE-2019-011: NVIDIA GeForce Experience Local Privilege Escalation 

### Vulnerability Type:
Privilege Escalation

### Vendors:
NVIDIA Corporation

### CVE ID:
CVE-2019-5701

### Affected Products:
- GeForce Experience version 3.20.0.118 and older

### Summary:
GeForce Experience version 3.20.0.118 and older suffer from local privilege escalation due to the lack of safe DLL loading. This vulnerability allows local non-privileged users to perform DLL Hijacking via any writable directory listed under the system path and ultimately execute code as `NT AUTHORITY\SYSTEM`.

### Mitigation:
The vendor has released a patch in version 3.20.1.57 addressing this vulnerability.

### Credit:
This vulnerability was found by Hashim Jawad of ACTIVELabs.

### References:
- https://nvidia.custhelp.com/app/answers/detail/a_id/4860
- http://cve.mitre.org/cgi-bin/cvename.cgi?name=CVE-2019-5701
- https://nvd.nist.gov/vuln/detail/CVE-2019-5701

### Disclosure Timeline:
- **09-03-19**: ACTIVELabs sent vulnerability details to NVIDIA PSIRT
- **09-04-19**: NVIDIA PSIRT acknowledge report and opened a case
- **09-11-19**: ACTIVELabs requested status update
- **09-11-19**: NVIDIA PSIRT responded that the product team is still working to reproduce the issue
- **09-13-19**: NVIDIA PSIRT requested additional information
- **09-13-19**: ACTIVELabs sent requested information
- **09-19-19**: ACTIVELabs sent supplementary vulnerability details to NVIDIA PSIRT
- **09-23-19**: ACTIVELabs requested status update
- **09-23-19**: NVIDIA PSIRT was able to reproduce the issue and patch is scheduled for release by the end of October
- **10-28-19**: ACTIVELabs requested an update and provided copy of draft blog post which will be published after patch release 
- **10-28-19**: NVIDIA PSIRT responded with details about release dates and requested blog post for review
- **10-28-19**: ACTIVELabs sent blog post draft
- **11-04-19**: Patch released
- **11-06-19**: NVIDIA security bulletin published
- **11-06-19**: CVE-2019-5701 assigned
- **11-07-19**: ACTIVELabs publishes this advisory
